Following the resolution of Eli Lilly’s tirzepatide shortage in October, the FDA has officially declared an end to the supply ...
The FDA has removed semaglutide from its drug shortage list after the agency determined the current supply of the drug can ...
A randomized, placebo-controlled trial validates a side effect frequently observed by doctors and patients. A new study from ...
Leerink notes that the shortage of Novo Nordisk’s (NVO) semaglutide, marketed as Wegovy and Ozempic, has been resolved according to the FDA.
The resolution could potentially restrict how telehealth programs offer cheaper versions known as compounded drugs ...